Skip to content
← All settings

DISEASE & TREATMENT SETTING

Liposarcoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Liposarcoma

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 6 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      10 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00346164 · Source cited / selected · Scope: narrower

      Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

      6 outcome links · 4 safety-group records · 0 quality-of-life measures

      →

      NCT00356031 · Registry condition search · Scope: narrower

      Bevacizumab and Radiation Therapy for Sarcomas

      6 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT00400569 · Registry condition search · Scope: narrower

      Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

      4 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT01653028 · Registry condition search · Scope: narrower

      Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

      4 outcome links · 5 safety-group records · 0 quality-of-life measures

      →

      NCT02048371 · Source cited / selected · Scope: narrower

      SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes

      6 outcome links · 8 safety-group records · 0 quality-of-life measures

      →

      NCT02180867 · Source cited / selected · Scope: narrower

      Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can

      6 outcome links · 7 safety-group records · 2 quality-of-life measures

      →

      NCT02500797 · Source cited / selected · Scope: narrower

      Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery

      6 outcome links · 8 safety-group records · 0 quality-of-life measures

      →

      NCT02584309 · Registry condition search · Scope: narrower

      Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma

      5 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT03132922 · Registry condition search · Scope: narrower

      MAGE-A4ᶜ¹º³²T for Multi-Tumor

      6 outcome links · 4 safety-group records · 0 quality-of-life measures

      →

      NCT03899805 · Registry condition search · Scope: narrower

      A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas

      4 outcome links · 3 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-liposarcoma
        binding id
        ncit-C3194
        source collection
        ncit-concept
        source key
        C3194
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice